NVS logo

Novartis AG (NVS) Return On Equity

Annual ROE

26.28%
-1.69%-6.04%

December 31, 2024

Summary

Performance

1-Year Change

-6.04%

3-Year Change

-31.9%

5-Year Change

+50.34%

15-Year Change

+154.4%

NVS ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

83.99%
NVS annual return on equity is higher than 83.99% of companies in Healthcare sector

High & Low

All-time High

38.59%
NVS annual return on equity is currently -31.90% below its historical high of 38.59%

3-Year Low

10.93%
NVS annual return on equity is currently +140.44% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
NVS previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
NVS next annual earnings announcement has not yet been scheduled

OtherNVSprofitabilitymetrics:

Annual Revenue

$51.72 B
NVS annual revenue is $51.72 billion

Annual Net Income

$11.94 B
NVS annual net profit is $11.94 billion

Annual EPS

$5.87
NVS annual earnings per share is $5.87

Annual ROA

11.81%
NVS annual return on assets is 11.81%

Quarterly ROE

27.64%
-14.25%-34.02%

December 31, 2024

Summary

Performance

3-Month Change

-34.02%

1-Year Change

-7.5%

3-Year Change

+85.25%

5-Year Change

+85.25%

NVS Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

85.73%
NVS quarterly return on equity is higher than 85.73% of companies in Healthcare sector

High & Low

All-time High

41.97%
NVS quarterly return on equity is currently -34.14% below its historical high of 41.97%

3-Year Low

11.12%
NVS quarterly return on equity is currently +148.56% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
NVS previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

Apr 23, 2025
NVS next earnings announcement is scheduled for Apr 23, 2025

OtherNVSprofitabilitymetrics:

Quarterly Revenue

$13.56 B
NVS quarterly revenue is $13.56 billion

Quarterly Net Income

$2.82 B
NVS quarterly net profit is $2.82 billion

Quarterly EPS

$1.41
NVS quarterly earnings per share is $1.41

Quarterly ROA

12.00%
NVS quarterly return on assets is 12.00%

ROE Formula

ROE =  Net Income
Shareholders Equity ✕ 100%

Annual ROE

26.28%
NVS annual return on equity is 26.28%

Annual Net Income

$11.94 B
NVS annual net profit is $11.94 billion

Annual Shareholders Equity

$44.05 B
NVS annual stockholders equity is $44.05 billion

NVS ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-6.0%-7.5%
3 y3 years-31.9%+85.3%
5 y5 years+50.3%+85.3%

NVS ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-31.9%+140.4%-34.1%+148.6%
5 y5-year-31.9%+140.4%-34.1%+148.6%
alltimeall time-31.9%+197.6%-34.1%+214.4%

Novartis AG ROE History

DateAnnualQuarterly
Dec 2024
26.28%(-6.0%)
27.64%(-34.0%)
Sep 2024
-
41.89%(+13.2%)
Jun 2024
-
37.00%(+11.1%)
Mar 2024
-
33.31%(+11.5%)
Dec 2023
27.97%(+155.9%)
29.88%(+100.3%)
Sep 2023
-
14.92%(+12.1%)
Jun 2023
-
13.31%(+12.6%)
Mar 2023
-
11.82%(+6.3%)
Dec 2022
10.93%(-71.7%)
11.12%(-68.3%)
Sep 2022
-
35.11%(-7.2%)
Jun 2022
-
37.85%(-8.9%)
Mar 2022
-
41.53%(-1.0%)
Dec 2021
38.59%(+168.2%)
41.97%(+133.6%)
Sep 2021
-
17.97%(+7.9%)
Jun 2021
-
16.65%(+11.6%)
Mar 2021
-
14.92%(+0.4%)
Dec 2020
14.39%(-17.7%)
14.86%(+12.0%)
Sep 2020
-
13.27%(-2.6%)
Jun 2020
-
13.63%(-42.1%)
Mar 2020
-
23.54%(+14.6%)
Dec 2019
17.48%(+6.0%)
20.54%(+7.3%)
Sep 2019
-
19.15%(+11.9%)
Jun 2019
-
17.12%(-2.4%)
Mar 2019
-
17.54%(+5.4%)
Dec 2018
16.49%(+59.6%)
16.64%(-7.3%)
Sep 2018
-
17.96%(-5.4%)
Jun 2018
-
18.99%(+67.5%)
Mar 2018
-
11.34%(+5.7%)
Dec 2017
10.33%(+17.0%)
10.73%(+15.6%)
Sep 2017
-
9.28%(+2.2%)
Jun 2017
-
9.08%(+3.3%)
Mar 2017
-
8.79%(-2.7%)
Dec 2016
8.83%(-63.3%)
9.03%(-1.0%)
Sep 2016
-
9.12%(+1.8%)
Jun 2016
-
8.96%(+0.6%)
Mar 2016
-
8.91%(-61.9%)
Dec 2015
24.04%(+71.1%)
23.40%(-3.9%)
Sep 2015
-
24.34%(-8.4%)
Jun 2015
-
26.56%(-5.8%)
Mar 2015
-
28.19%(+97.4%)
Dec 2014
14.05%(+10.0%)
14.28%(-4.6%)
Sep 2014
-
14.97%(+9.6%)
Jun 2014
-
13.66%(-0.6%)
Mar 2014
-
13.74%(+5.6%)
Dec 2013
12.77%(-6.9%)
13.01%(-1.6%)
Sep 2013
-
13.22%(-3.9%)
Jun 2013
-
13.76%(-3.3%)
Mar 2013
-
14.23%(+1.3%)
Dec 2012
13.71%
14.05%(+10.8%)
Sep 2012
-
12.68%(-0.9%)
DateAnnualQuarterly
Jun 2012
-
12.80%(-0.3%)
Mar 2012
-
12.84%(-4.0%)
Dec 2011
13.18%(-14.4%)
13.37%(-11.5%)
Sep 2011
-
15.10%(-1.2%)
Jun 2011
-
15.29%(-0.8%)
Mar 2011
-
15.42%(-4.1%)
Dec 2010
15.40%(-1.1%)
16.08%(-6.7%)
Sep 2010
-
17.24%(-3.7%)
Jun 2010
-
17.91%(+0.4%)
Mar 2010
-
17.84%(+9.6%)
Dec 2009
15.57%(-5.2%)
16.28%(+7.2%)
Sep 2009
-
15.19%(-0.6%)
Jun 2009
-
15.28%(-3.2%)
Mar 2009
-
15.79%(-3.1%)
Dec 2008
16.42%(-37.7%)
16.30%(+8.0%)
Sep 2008
-
15.09%(-40.4%)
Jun 2008
-
25.34%(-2.7%)
Mar 2008
-
26.03%(-2.2%)
Dec 2007
26.34%(+36.7%)
26.62%(-10.5%)
Sep 2007
-
29.73%(+55.4%)
Jun 2007
-
19.13%(-1.0%)
Mar 2007
-
19.33%(-0.9%)
Dec 2006
19.27%(+1.4%)
19.50%(-1.0%)
Sep 2006
-
19.70%(-1.7%)
Jun 2006
-
20.04%(-3.8%)
Mar 2006
-
20.83%(+6.0%)
Dec 2005
19.01%(+9.6%)
19.66%(+5.1%)
Sep 2005
-
18.70%(+1.0%)
Jun 2005
-
18.52%(+1.0%)
Mar 2005
-
18.33%(+4.2%)
Dec 2004
17.35%(+7.6%)
17.59%(-3.9%)
Sep 2004
-
18.30%(+1.9%)
Jun 2004
-
17.96%(+3.1%)
Mar 2004
-
17.42%(+4.1%)
Dec 2003
16.12%(-8.0%)
16.73%(-5.2%)
Sep 2003
-
17.64%(+3.2%)
Jun 2003
-
17.09%(-2.2%)
Mar 2003
-
17.48%(-6.0%)
Dec 2002
17.53%(+10.7%)
18.60%(+8.2%)
Sep 2002
-
17.19%(-2.6%)
Jun 2002
-
17.65%(+4.6%)
Mar 2002
-
16.88%(+0.6%)
Dec 2001
15.84%(-17.8%)
16.78%(-17.3%)
Sep 2001
-
20.29%(+8.6%)
Jun 2001
-
18.69%(-2.1%)
Mar 2001
-
19.10%(-4.1%)
Dec 2000
19.26%(+7.0%)
19.91%(+35.0%)
Sep 2000
-
14.75%(+34.5%)
Jun 2000
-
10.97%
Dec 1999
18.00%(-6.0%)
-
Dec 1998
19.14%
-

FAQ

  • What is Novartis AG annual return on equity?
  • What is the all time high annual ROE for Novartis AG?
  • What is Novartis AG annual ROE year-on-year change?
  • What is Novartis AG quarterly return on equity?
  • What is the all time high quarterly ROE for Novartis AG?
  • What is Novartis AG quarterly ROE year-on-year change?

What is Novartis AG annual return on equity?

The current annual ROE of NVS is 26.28%

What is the all time high annual ROE for Novartis AG?

Novartis AG all-time high annual return on equity is 38.59%

What is Novartis AG annual ROE year-on-year change?

Over the past year, NVS annual return on equity has changed by -1.69% (-6.04%)

What is Novartis AG quarterly return on equity?

The current quarterly ROE of NVS is 27.64%

What is the all time high quarterly ROE for Novartis AG?

Novartis AG all-time high quarterly return on equity is 41.97%

What is Novartis AG quarterly ROE year-on-year change?

Over the past year, NVS quarterly return on equity has changed by -2.24% (-7.50%)